Literature DB >> 18462327

Complications of catheter ablation for atrial fibrillation: incidence and predictors.

David D Spragg1, Darshan Dalal, Aamir Cheema, Daniel Scherr, Karuna Chilukuri, Alan Cheng, Charles A Henrikson, Joseph E Marine, Ronald D Berger, Jun Dong, Hugh Calkins.   

Abstract

INTRODUCTION: Pulmonary vein (PV) isolation by catheter ablation is an increasingly used strategy to treat atrial fibrillation (AF). Complication rates from AF ablation reported in different case series vary widely. We conducted a retrospective analysis of 641 consecutive ablation procedures to assess complication rates, temporal trends, and clinical predictors of adverse outcomes.
METHODS: All patients (n = 517) undergoing catheter ablation for AF at Johns Hopkins Hospital between February, 2001 and June, 2007 were prospectively enrolled in a database. Data from 641 consecutive procedures were analyzed and complications considered if they occurred within 30 days of ablation. Major complications were defined as those that required intervention, resulted in long-term disability, or prolonged hospitalization.
RESULTS: Thirty-two major complications occurred in 641 procedures (5%). Among the patients with major complications, seven had cerebrovascular accident (CVA), eight had tamponade, one had PV occlusion with hemoptysis, and 11 had vascular injury requiring surgical repair and/or transfusion. No periprocedural deaths occurred, and no instances of esophageal injury were seen. Complication rates were higher during the first 100 cases (9.0%) than during the subsequent 541 (4.3%). Major adverse clinical events were associated with age > 70 years (P = 0.007; odds ratio 3.7, 95% confidence interval 1.4-9.6) and female gender (P = 0.014; odds ratio 3.0, 95% confidence interval 1.3-7.2). No other clinical or procedural predictors of complication were identified.
CONCLUSIONS: Complication rates from AF ablation remain significant, despite improved techniques and increased awareness of procedural risks. Both advanced age and female gender predict major adverse events, suggesting careful consideration of the risk/benefit profile in these patients prior to ablation.

Entities:  

Mesh:

Year:  2008        PMID: 18462327     DOI: 10.1111/j.1540-8167.2008.01181.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  76 in total

1.  Cardiac tamponade following pericarditis 18 days after catheter ablation of atrial fibrillation.

Authors:  T Lambert; C Steinwender; F Leisch; R Hofmann
Journal:  Clin Res Cardiol       Date:  2010-05-09       Impact factor: 5.460

2.  Clinical experience with routine use of a single combined mapping and ablation catheter for isolation of pulmonary veins in patients with paroxysmal atrial fibrillation.

Authors:  Clemens Steinwender; Simon Hönig; Franz Leisch; Robert Hofmann
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

3.  Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.

Authors:  Melanie Gunawardene; S Willems; B Schäffer; J Moser; R Ö Akbulak; M Jularic; C Eickholt; J Nührich; C Meyer; P Kuklik; S Sehner; V Czerner; B A Hoffmann
Journal:  Clin Res Cardiol       Date:  2016-07-19       Impact factor: 5.460

Review 4.  State-of-the-art and emerging technologies for atrial fibrillation ablation.

Authors:  Jane Dewire; Hugh Calkins
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

5.  Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation.

Authors:  Daniel W Kaiser; Jun Fan; Susan Schmitt; Claire T Than; Aditya J Ullal; Jonathan P Piccini; Paul A Heidenreich; Mintu P Turakhia
Journal:  JACC Clin Electrophysiol       Date:  2016-11

6.  The role of nuclear medicine in diagnosing complications related to catheter-based AF ablation.

Authors:  Wilson Vallat; Steven A Unger
Journal:  J Nucl Cardiol       Date:  2011-12       Impact factor: 5.952

7.  Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin.

Authors:  Christine C Tanaka-Esposito; Mina K Chung; Joellyn M Abraham; Daniel J Cantillon; Bernard Abi-Saleh; Patrick J Tchou
Journal:  J Interv Card Electrophysiol       Date:  2013-04-14       Impact factor: 1.900

8.  Postprocedural neuropathy after atrial fibrillation ablation.

Authors:  Yeruva Madhu Reddy; Dhssraj Singh; Vineela Chikkam; Sudharani Bommana; Donita Atkins; Atul Verma; Vijay Swarup; Yariv Khaykin; Srinivas Nalamachu; Mamatha Pasnoor; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2012-12-09       Impact factor: 1.900

9.  A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation.

Authors:  Ping Xia; Rupesh Kotecha; Naveen Sharma; Martin Andrews; Kevin L Stephans; Carlos Oberti; Sara Lin; Oussama Wazni; Patrick Tchou; Walid I Saliba; John Suh
Journal:  Cureus       Date:  2016-07-11

10.  Stroke risk associated with balloon based catheter ablation for atrial fibrillation: Rationale and design of the MACPAF Study.

Authors:  Karl Georg Haeusler; Lydia Koch; Juliane Ueberreiter; Matthias Endres; Heinz-Peter Schultheiss; Peter U Heuschmann; Alexander Schirdewan; Jochen B Fiebach
Journal:  BMC Neurol       Date:  2010-07-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.